Erlotinib
NDC 59651-532, Erlotinib, tablet, film coated, from Aurobindo Pharma Limited.
- Product NDC
- 59651-532
- Status
- Listed
- Labeler
- Aurobindo Pharma Limited
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA216342
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/59651-532 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- ERLOTINIB HYDROCHLORIDE150 mg/1
Pharmacologic classes
Kinase Inhibitor [EPC]; Protein Kinase Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 59651-532-03 | 59651053203 | 30 TABLET, FILM COATED in 1 BOTTLE (59651-532-03) |
| 59651-532-10 | 59651053210 | 1 BLISTER PACK in 1 CARTON (59651-532-10) / 10 TABLET, FILM COATED in 1 BLISTER PACK |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/3ecafc1e-979a-4aff-a276-18fc0b110491
Use it
Look up 59651-532 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/59651-532 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 59651-532. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.